POLYMORPHIC FORM OF CHALCONE GLYCOSIDE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF

Sulfinate glycosyl donor, method for preparing same, and use thereof

METHOD FOR PREPARING ARYL CARBON GLYCOSIDE COMPOUND INCLUDING GLIFLOZIN DRUG

CARBOHYDRATE DERIVATIVES AND KITS FOR CELL SURFACE LABELING

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT

MANNOSE 6-PHOSPHATE OR ASGPR RECEPTOR BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS

COMPOUNDS FOR TARGETED PROTEIN DEGRADATION

HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS

C-MANNOSIDE COMPOUNDS USEFUL FOR THE TREATMENT OF URINARY TRACT INFECTIONS

Modular synthesis of aminoglycosides

TREATMENT OF METABOLIC DISORDERS IN FELINE ANIMALS

Modular synthesis of aminoglycosides

CRYSTAL FORM OF SGLT INHIBITOR AND APPLICATION THEREOF

Oligosaccharide C-glycoside derivatives

CONTINUOUS PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN

Mannose derivatives for treating bacterial infections

Synthesis of 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(ß-d-glucopyranos-1-yl)-benzene, L-proline and water

C-mannoside compounds useful for the treatment of urinary tract infections

GLUCOPYRANOSE DERIVATIVES USEFUL AS SGLT2 INHIBITORS

GLUCOPYRANOSE DERIVATIVES USEFUL AS SGLT2 INHIBITORS

Highly potent multimeric e-selectin antagonists

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT

Process for the preparation of SGLT2 inhibitors and intermediates thereof

Synthesis of 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene, L-proline and water

Glucopyranosyl derivative and use thereof

C-mannoside compounds useful for the treatment of urinary tract infections

Oligosaccharide c-glycoside derivatives

Processes for the preparation of SGLT-2 inhibitors, intermediates thereof

2,7-dibromospiro[fluorene-9,4′-piperidine] compounds

Crystalline form of benzylbenzene SGLT2 inhibitor

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT

Treatment of metabolic disorders in feline animals

Crystal form of sodium-glucose cotransporter 2 inhibitor

Process for the preparation of SGLT2 inhibitors and intermediates thereof

Pattern forming method, under coating agent, and laminate

Crystal form of dapagliflozin intermediate and preparation method therefor

Silylated derivatives of resveratrol and the use thereof in neurodegenerative, neurological or inflammatory diseases

Highly potent multimeric e-selectin antagonists

Amine solvate of sodium-glucose linked transporter inhibitor, and preparation method and application thereof

Mangiferin-6-O-calcium salt and preparation process thereof

Mannose derivatives for treating bacterial infections

SODIUM GLUCOSE CO-TRANSPORTER INHIBITORS AND METHODS OF THEIR USE

METHOD FOR PRODUCING ALPHA-HALO-TETRAACYL-GLUCOSE

Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereof

C-glucoside derivative containing fused phenyl ring or pharmaceutically acceptable salt thereof, process for preparing same, and pharmaceutical composition comprising same

Processes for the preparation of SGLT-2 inhibitors, intermediates thereof

Complex of a glucopyranosyl derivative and preparation method and use thereof

Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same

GLUCOPYRANOSIDE COMPOUND

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT

Process for preparation of dapagliflozin

Crystalline form of benzylbenzene SGLT2 inhibitor

Process for the preparation of SGLT inhibitor compounds

Bicyclic derivatives and pharmaceutical composition including the same

Glycoside derivatives and uses thereof

C-aryl glycosid derivatives, pharmaceutical composition, preparation process and uses thereof

Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same

Dapagliflozin crystalline form and preparation method thereof

Process for the preparation of empagliflozin

Mannose derivatives for treating bacterial infections

C-aryl glucoside derivative, preparation methods thereof, and medical applications thereof

Crystalline form of 1-(beta-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene and preparation method thereof

Process for the preparation of benzylbenzene SGLT2 inhibitors

Crystalline hydrates of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene

GLUCOPYRANOSIDE COMPOUND

Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl) cytosine, synthetic intermediate of thionucleoside, and method for producing the same

METHOD FOR PRODUCING a-HALO-TETRAACYL-GLUCOSE

PROCESS FOR PREPARATION AND PURIFICATION OF CANAGLIFLOZIN

Glycomimetics as lectin inhibitors

Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein

AMORPHOUS FORM OF DAPAGLIFLOZIN 1,2-PROPANEDIOL

Glucopyranosyl derivatives and their uses in medicine

Crystalline form of benzylbenzene SGLT2 inhibitor

Optically pure benzyl-4-chlorophenyl-C-glucoside derivative

Treatment of metabolic disorders in feline animals

Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same

Enterobactin conjugates and uses thereof

Hydroxysafflor yellow A sodium and preparation as well as application thereof

Bioactive alkaloid compositions and their medical uses

Crystalline dapagliflozin hydrate

GLUCOPYRANOSIDE COMPOUND

GLYCOSIDE DERIVATIVES AND USES THEREOF

Mannose derivatives for treating bacterial infections

NOVEL SGLT INHIBITORS

Sodium glucose co-transporter inhibitors and methods of their use

NOVEL ARYL C-XYLOSIDE COMPOUNDS, AND COSMETIC USE

Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof

Crystalline complex of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(ss-d-glucopyranos-1-yl)-benzene, methods for its preparation and the use thereof for preparing medicaments

Benzylbenzene derivatives and methods of use

Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives

Crystalline form of benzylbenzene SGLT2 inhibitor

Crystal structures of SGLT2 inhibitors and processes for preparing same

Process for the preparation of benzylbenzene SGLT2 inhibitors

MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS

SYNTHETIC GLYCOAMINE COMPOUNDS

Derivatives of glyco-CF-serine and glyco-CF-threonine

Methods of treating diabetes

Glycoside compounds

METHODS OF TREATMENT, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

Dendritic starch-based dextrin adhesives

Thiazole derivatives as SGLT2 inhibitors and pharmaceutical composition comprising same

Neuro-protective compounds and their use

Phenyl C-glucoside derivatives, preparation methods and uses thereof

Glycoside derivatives and uses thereof

Benzylbenzene derivatives and methods of use

Glucopyranoside compound

CRYSTALLINE FORM OF BENZYLBENZENE SGLT2 INHIBITOR

Amphiphilic compositions and methods for preparing and using same

Foliamangiferosides, preparation method and use thereof

Glycoside derivatives and uses thereof

Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors

Aryl C-xyloside compounds, and cosmetic use

Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives

Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate

Benzylbenzene derivatives and methods of use

Crystal structures of SGLT2 inhibitors and processes for preparing same

Glycoside derivatives and uses thereof

COMPOUNDS WITH GLYCIDIC STRUCTURE ACTIVE IN THE THERAPY OF SYSTEMIC AND LOCAL INFLAMMATION

Method for treating hyponatremia employing an SGLT2 inhibitor and composition containing same

Method for treating and preventing kidney stones employing an SGLT2 inhibitor and composition containing same

Nucleoside Phosphonate Analogs

Method for treating hyperuricemia employing an SGLT2 inhibitor and composition containing same

Combination therapy comprising SGLT inhibitors and DPP4 inhibitors

Novel aromatic fluoroglycoside derivatives, pharmaceuticals comprising said compounds and the use thereof

C-aryl glycoside compounds for the treatment of diabetes and obesity

Glucopyranoside derivatives

PHARMACEUTICAL COMPOSITIONS FOR TREATING FATTY LIVER DISEASE

Crystalline form of 4-(beta-D-glucopyranos-1-yl)-1-methyl-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments

Sulfanyl-tetrahydropyran-based compounds and methods of their use

Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture

Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivates and intermediates therein

Strongly quenching oligomeric excimer/quencher pairs for detection schemes

Process for the preparation of compounds useful as inhibitors of SGLT

Tetrasubstituted glucopyranosylated benzene derivatives, medicaments containing such compounds, their use and process for their manufacture

Glucopyranosyl-substituted benzyl-benzonitrile derivates, medicaments containing such compounds, their use and process for their manufacture

Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol and methods of their use

C-phenyl 1-thioglucitol compound

Anti-hypercholesterolemic compounds

Glucopyranosyl-substituted difluorobenzyl-benzene derivates, medicaments containing such compounds, their use and process for their manufacture

Benzylphenyl cyclohexane derivatives and methods of use

BIPHENYLAZETIDINONE CHOLESTEROL ABSORPTION INHIBITORS

Benzylbenzene derivatives and methods of use

Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors

Phenylazetidinone Derivatives

CRYSTAL STRUCTURES OF SGLT2 INHIBITORS AND PROCESSES FOR PREPARING SAME

Benzylic glycoside derivatives and methods of use

4-Biarylyl-1-Phenylazetidin-2-One Glucuronide Derivatives for Hypercholesterolemia

4-BIARYLYL-1-PHENYLAZETIDIN-2-ONES

Crystalline form of 1-(β-D-glucopyransoyl)-4-methyl-3-[5-(4-fluorophenyl)-2- thienylmethyl]benzene hemihydrate

Inhibitors of sodium glucose co-transporter 2 and methods of their use

Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture

Crystal structures of SGLT2 inhibitors and processes for preparing same

Process for Production of Azulene Derivatives and Intermediates for the Synthesis of the Same

Glucose transport inhibitors and methods of use

Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture

Neuraminidase inhibitor

Processes for preparing of glucopyranosyl-substituted (ethynyl-benzyl)-benzene derivatives and intermediates thereof

Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture

Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein

Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture

D-pyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture

C-aryl glucoside SGLT2 inhibitors and method

D-xylopyranosyl-phenyl-substituted cycles, medicaments containing such compounds, their use and process for their manufacture

D-xylopyranosyl-phenyl-substituted cycles, medicaments containing such compounds, their use and process for their manufacture

Methylidene-D-xylopyranosyl- and oxo-D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture

D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture

Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae

Nucleoside phosphonate analogs

4-Biarylyl-1-phenylazetidin-2-ones

Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae